前沿论文｜CELL INTELLIGENCE

Reprogramming the immune microenvironment in triple-negative breast cancer with mRNA therapeutics.

PubMed 2026/02/21 发表Cancer LettQ1 · IF 11.8（JCR 2025）

A new immunotherapy ROR: Proximal ROR1 domain targeting breast cancer via monoclonal antibodies and CAR NK cells.

PubMed 2026/02/19 发表Mol TherQ1 · IF 11.4（JCR 2025）

Phase I Study of ROR1-Specific CAR-T Cells in Advanced Hematopoietic and Epithelial Malignancies.

PubMed 2025/02/03 发表Clin Cancer ResQ1 · IF 10.9（JCR 2025）

ROR1 CAR-T 细胞在大多数患者中耐受良好。

Tumour assessment of ROR1 levels in various adult leukaemia and lymphoma types.

PubMed 2024/11/04 发表PLoS OneQ2 · IF 2.8（JCR 2025）

前沿论文 4